Question

Difficulty: MediumMenstrual Cycle Abnormalities and Contraception

Presenting to the gynecology office for the evaluation of persistent vaginal bleeding, a 39-year-old female reports that her current bleeding episode has lasted for four consecutive weeks. Prior to the onset of this bleeding, she had not menstruated for six months. She has a known medical history of polycystic ovary syndrome (PCOS), diagnosed when she was 22, and obesity. Additionally, she reports a two-year history of episodic, severe unilateral headaches that are reliably preceded by flashing visual zig-zags; she uses over-the-counter ibuprofen for relief. She recently entered a new relationship and specifically requests a daily birth control pill to prevent pregnancy and to help regulate her cycle. Her body mass index is 37 kg/m237 \text{ kg/m}^2. Vital signs are within normal limits. A urine beta-hCG test performed in the clinic today is negative. Pelvic examination demonstrates a normal-sized, non-tender uterus and no adnexal masses. Which of the following is the most appropriate next step in the management of this patient?

  1. Endometrial biopsyAnswer
  2. B
    Transvaginal ultrasonography
  3. C
    Prescription of combined oral contraceptive pills
  4. D
    Measurement of serum 17-hydroxyprogesterone
  5. E
    Measurement of serum thyroid-stimulating hormone and free T4

Answer

Endometrial biopsy is the required next step to evaluate the endometrium for hyperplasia or malignancy due to her risk factors.
This patient presents with abnormal uterine bleeding (AUB) in the setting of chronic anovulation (PCOS) and obesity. These clinical factors result in prolonged, unopposed estrogen exposure, which significantly increases the risk of developing endometrial hyperplasia and endometrial adenocarcinoma. While the general age threshold for evaluating AUB with a routine endometrial biopsy is 45 years, an immediate biopsy is strictly indicated in women younger than 45 if they possess high-risk factors such as obesity, chronic anovulation, or failed previous medical management. Therefore, performing an endometrial biopsy is the most critical next step to rule out malignancy before any symptomatic or contraceptive treatment is initiated.

Step-by-Step Solution

1
Evaluate the patient's presentation of abnormal uterine bleeding (AUB).
The patient is a 39-year-old experiencing a 4-week episode of heavy bleeding following 6 months of amenorrhea, on a background of long-standing PCOS and obesity.
Identifying the pattern of bleeding and associated risk factors is critical for determining the need for invasive diagnostic testing.
2
Apply the criteria for structural endometrial evaluation in premenopausal women.
Although she is under age 45, her history of chronic anovulation (PCOS) and high body mass index places her at significant risk for endometrial hyperplasia and carcinoma.
Guidelines mandate an endometrial biopsy for women under 45 with AUB if they have risk factors for prolonged, unopposed estrogen exposure.
3
Evaluate the patient's specific request for a combined oral contraceptive pill.
The patient has a history of severe headaches preceded by visual auras, diagnostic of migraine with aura.
Estrogen-containing contraceptives are absolutely contraindicated (WHO MEC Category 4) in patients with migraine with aura due to a highly elevated risk of ischemic stroke.

Key Concept

Premenopausal women with abnormal uterine bleeding and risk factors for unopposed estrogen exposure (e.g., obesity, PCOS) require an endometrial biopsy to rule out malignancy before initiating medical therapy.
Estimated Time:1m 15s
Rate this question